Annual clinical follow-up appointments are recommended to monitor aminotransferases and to monitor markers of insulin resistance using homeostatic model assessment HOMA.
Se recomienda monitoreo clínico anual y seguimiento con aminotransferasas y marcadores de resistencia a la insulina HOMA.